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Transcript-Specific Expression Profiles Derived from
Sequence-Based Analysis of Standard Microarrays
Abstract
Background: Alternative mRNA processing mechanisms lead to multiple transcripts (i.e. splice
isoforms) of a given gene which may have distinct biological functions. Microarrays like Affymetrix
GeneChips measure mRNA expression of genes using sets of nucleotide probes. Until recently probe
sets were not designed for transcript specificity. Nevertheless, the reanalysis of established microarray
data using newly defined transcript-specific probe sets may provide information about expression levels
of specific transcripts. Methodology/Principal Findings: In the present study alignment of probe
sequences of the Affymetrix microarray HGU133A with Ensembl transcript sequences was performed
to define transcript-specific probe sets. Out of a total of 247,965 perfect match probes, 95,008 were
designated ‘‘transcript-specific'', i.e. showing complete sequence alignment, no crosshybridization, and
transcript-, not only gene-specificity. These probes were grouped into 7,941 transcript-specific probe
sets and 15,619 gene-specific probe sets, respectively. The former were used to differentiate 445
alternative transcripts of 215 genes. For selected transcripts, predicted by this analysis to be
differentially expressed in the human kidney, confirmatory real-time RT-PCR experiments were
performed. First, the expression of two specific transcripts of the genes PPM1A (PP2CA_HUMAN and
P35813) and PLG (PLMN_HUMAN and Q5TEH5) in human kidneys was determined by the
transcriptspecific array analysis and confirmed by real-time RT-PCR. Secondly, disease-specific
differential expression of single transcripts of PLG and ABCA1 (ABCA1_HUMAN and
Q5VYS0_HUMAN) was computed from the available array data sets and confirmed by
transcript-specific real-time RT-PCR. Conclusions: Transcript-specific analysis of microarray
experiments can be employed to study gene-regulation on the transcript level using conventional
microarray data. In this study, predictions based on sufficient probe set size and foldchange are
confirmed by independent means
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Background: Alternative mRNA processing mechanisms lead to multiple transcripts (i.e. splice isoforms) of a given gene
which may have distinct biological functions. Microarrays like Affymetrix GeneChips measure mRNA expression of genes
using sets of nucleotide probes. Until recently probe sets were not designed for transcript specificity. Nevertheless, the re-
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specific array analysis and confirmed by real-time RT-PCR. Secondly, disease-specific differential expression of single
transcripts of PLG and ABCA1 (ABCA1_HUMAN and Q5VYS0_HUMAN) was computed from the available array data sets and
confirmed by transcript-specific real-time RT-PCR.
Conclusions: Transcript-specific analysis of microarray experiments can be employed to study gene-regulation on the
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Introduction
DNA microarrays are important experimental tools to gain
knowledge about the steady state levels of mRNA species.
Affymetrix GeneChips were designed to contain a series of
oligonucleotide probes complementary to a specific mRNA of
known genes. To quantify a specific mRNA species, the signals
from a group of probes (i.e. probe sets) representing a specific gene
are normalized and averaged (e.g. [1]). However, often the design
of the array and the selection of probe sequences were finalized
before the human genome was fully annotated. Therefore some
probes lack specificity and the conventional probe sets do not
always reflect current knowledge about the multiple individual
transcripts encoded by the same gene. Furthermore, mRNA
processing mechanisms can lead to different transcripts of the
same gene which can have specific biological functions [1,2].
Methods that apply microarray profiling would – by using the
available and measured transcript-specific probes – provide
additional information not on the expression levels of a gene but
also the respective splice isoforms.
Several tools have been developed to customize the analysis of
gene expression data. Novel mapping of given probe sequences
to more recent genomic data was performed by Gautier et al. [3]
and Harbig et al. [4]. Both groups were able to show that re-
mapping of the probe sequences affects data analysis for specific
arrays. Dai et al. [5] introduced re-defined probe sets after re-
alignments of probe sequences to genes as well as transcripts.
However, as probes of a given probe set were allowed to match
several different transcripts, their overall signal will still be
influenced by several transcripts. Additional alignment algo-
rithms were used to define transcript-specific probe sets
employing different databases as RefSeq or AceView [6,7].
However, none of these reports experimentally validated
alternative transcript expression.
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Independent confirmatory experiments by real-time RT-PCR
or other techniques are clearly advisable for any microarray results
obtained with a modified measurement or analysis protocol [8].
The goal of the present work was to annotate probe sequences of
the widely employed microarray Affymetrix HG-U133A to
Ensembl transcript definitions and select probes whose sequences
are specific and suitable to estimate expression of transcripts. Re-
defined transcript-specific probe sets were used on available
microarray data of human renal tissue [9] to predict the expression
of individual transcripts. Two potential biological differences in the
expression profile of transcripts were analyzed: First, genes having
a lowly as well as a highly abundant transcript in healthy human
renal tissue were searched. Secondly, genes were selected with
differentially regulated transcripts between normal renal tissue and
tissue from kidney patients. From both analyses, two genes were
selected for confirmatory experiments and their respective
transcript expression levels quantified using transcript-specific
real-time RT-PCR on the identical mRNA used for array
hybridization.
Results
Defining transcript- and gene-specific probe sequences
To determine transcript-specific expression information from
the HG-U133A microarray, individual probe sequences were first
aligned to Ensembl transcript sequences, then grouped to
transcript-specific probe sets, which were employed in robust
multiarray average analysis (RMA, see Methods).
In the Blast analysis two types of alignments were exploited:
‘‘exact alignment’’, i.e. 100% sequence identity over 25 base pairs
of transcript and probe sequence, and ‘‘near-exact alignment’’
with at most one mismatch (identity of 24 base pairs). We defined
transcript-specific probes to have one ‘‘exact alignment’’ with a
transcript, but no ‘‘exact alignment’’ in other transcripts, and no
‘‘near-exact alignment’’. For gene-specific probes the same
definition was used with respect to alignments to transcript
sequences of one gene (instead of alignment to one transcript).
Probes showing evidence for cross-hybridization (‘‘exact align-
ments’’ to transcript sequences of more than one gene) were
excluded from this study. The alignment of probes to Ensembl
transcripts gave 95,008 transcript-specific and 180,403 gene-
specific probes out of a total of 247,965 probes (Table 1,
supporting tables S1 and S2, and dataset S1).
To roughly test the characteristics of the transcript- and gene-
specific probes, five probe categories were defined: transcript-
specific, gene-specific (both as defined above), non-perfect match
probes (alignments with gaps or mismatches), no-match probes (no
alignment with an e-value smaller than 1), and negative control
probes (non-human sequence, indicated by the manufacturer).
Probes with transcript- or gene-specific alignments were expected
to show higher signal intensities in an experiment due to more
complete template hybridization compared to non-perfect match,
no-match, or negative control probes. This was tested on data
from human renal tissue. Signal intensity histograms of probes of
the above categories were plotted from a single array experiment
(Figure 1). Non-perfect match probes had, as expected, a similar
intensity distribution as probes with no match. Gene-specific
probes showed an almost identical distribution compared to
transcript-specific probes. These specific probes had a higher
percentage of probes with high intensity signals compared to non-
perfect or no match probes: Choosing the 95%-quantile of the
intensities of non-human control probes a higher fraction of gene-
and transcript-specific probes showed intensities above this
threshold than non-perfect or no-match probes (33.8%, 33.7%,
21.1%, 18.8%; respectively). The specific probes showed higher
signal intensities than non-specific probes probably due to
complete hybridization with corresponding templates. A few
non-specific probes showed also high signal intensities potentially
corresponding to as of yet unidentified transcripts (in Ensembl).
Grouping such individual probes to probe sets resulted in 7,941
transcript-specific probe sets and 15,619 gene-specific probe sets.
The general size of probe sets were multiples of 11, since the
original HG-U133A array probe sets consist of 11 probes each.
The transcript-specific probe sets were then ‘‘re-annotated’’ to the
respective gene to determine how many individual transcripts
could be quantified for a specific gene. For 215 genes, two or more
transcripts were covered by the newly defined transcript-specific
probe sets with a minimal probe set size of 1 (Table 2). A minimal
probe set size of 3 reduced the number of genes to 141 (136 genes
with 2 transcripts, 4 genes with 3 transcripts, 1 gene with 4
transcripts).
The newly defined probe sets were then used to analyze human
renal gene expression data to predict transcript-specific expression
profiles further to be confirmed by real-time RT-PCR.
Analysis of high and low abundant renal mRNA
transcripts
To test the alignment data and to identify genes with differential
expression of alternative transcripts in human renal tissue,
transcript levels for two genes were first tested based on the newly
defined transcript-specific probe sets. Expression levels were then
validated in a confirmatory experiment by real-time RT-PCR
using the same cDNA hybridized on the array. For this
experiment four transcripts of two genes were selected from
expression data of human kidneys (living allograft donors (LD);
n = 3) with the following rationale: The distributions of transcript-
specific probe intensities appeared distinguishable (no or little
overlap of probe intensities between the transcripts) and the
number of probes for each transcript was at least 3. For both
selected genes, PPM1A and PLG, two transcripts have been
annotated in Ensembl and for each transcript, 6 to 11 specific
probes are available on the array. In the case of gene PPM1A
higher signal levels of the probe set for transcript PP2CA_HU-
Table 1. Transcript-specificity of HG-U133A probes to
Ensembl transcripts.
number of probes number of transcripts
56388 0
95008 1
50011 2
19901 3
9836 4
5131 5
2895 6
1721 7
… …
1 44
1 50
The number of probes with at least one ‘‘exact alignment’’ with a transcript, and
no ‘‘near-exact alignments’’ were computed and grouped by the number of
different transcripts they have an ‘‘exact alignment’’ with. The probes in this
table with number of transcripts equal to 1 are the transcript-specific probes.
doi:10.1371/journal.pone.0004702.t001
Transcript Analysis
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MAN were observed than of the probe set for the second transcript
P35813-2 (7.860 and 3.660.1, respectively; p,0.001). For the
gene PLG the probe set for transcript PLMN_HUMAN showed
higher signal intensities than the one for the transcript
Q5TEH5_HUMAN (9.460.4 and 3.460.1, respectively;
p,0.01) (see Figure 2).
Real-time RT-PCR quantification of the transcripts on
independent kidney samples (tumor nephrectomies (TN); n= 6)
gave transcript-specific expression values in agreement with the
transcript-specific expression pattern generated with the micro-
array expression data (PPM1A: PP2CA_HUMAN: 8.762.5;
P35813-2: 160.4, p,0.001; PLG: PLMN_HUMAN 217.86
125.8; Q5TEH5_HUMAN 160.6, p,0.01) (see Figure 2). This
‘‘qualitative’’ approach – although problematic due to comparison
of signal intensities of different microarray probes which have
different hybridization efficiencies (see e.g. [10]) – underlined the
prospects of a transcript-specific analysis, which were further
studied on the quantitative level as follows.
Analysis of quantitative differences in renal mRNA
transcripts
To find genes that showed transcript-specific alterations
between different patient cohorts, two analyses were performed:
Expression profiles from renal allografts from LD (n= 3) were
compared to renal biopsies from deceased (cadaveric) allograft
donors (DD; n= 4) and the same LD expression data were
compared to renal biopsies from patients with diabetic nephrop-
athy (DN; n= 10). After background-correction, quantile normal-
ization and summarization according to transcript-specific probe
set definition (see methods) these data were analyzed for fold
changes and q-values using significance analysis of microarrays
(SAM) [11]. Genes with i) a quotient of maximal to minimal
transcript-specific fold change of at least 1.5 and ii) at least one
transcript with q-value,0.1 between LD vs. DD or LD vs. DN,
respectively, were considered for experimental confirmation. Nine
genes for LD versus DD and four genes for LD versus DN passed
these filter criteria. Two differentially expressed transcripts from
two genes were selected based on probe set size consideration.
These isoforms had at least six probes per probe set. Transcript
PLMN_HUMAN of the PLG gene showed reduced expression in
DD compared to LD while transcript Q5TEH5_HUMAN of the
same gene was not altered in expression. For gene ABCA1,
transcript ABCA1_HUMAN was induced in DN compared to LD
and transcript Q5VYS0_HUMAN was not changed in DN (see
Table 3 and Figure 3).
The transcripts selected were again quantified using real-time
RT-PCR. Results are displayed in Figure 3 and confirm a
concordant differential expression compared to microarray data
for PLG for both transcripts (PLMN_HUMAN: LD 160.4; DD
0.260.2, p,0.05; Q5TEH5_HUMAN: LD 161.3; DD 0.760.4,
n.s.). The induction of the transcript ABCA1_HUMAN in DN
observed in the microarray data was also confirmed by real-time
RT-PCR (LD 160.4, DN 5.463.5, p,0.05). The signals for
Q5VYS0 in real-time RT-PCR were too low to be quantified
probably due to low mRNA expression.
Discussion
Default annotation of first and second generation Affymetrix
microarrays such as HG-U133A is not compatible with up-to-date
transcript information and does not allow the selective analysis of
specific transcripts. The latest generations of microarrays, like exon
arrays or tiling arrays, address transcript expression analysis by an
increased number of probes and respective selection of probe
sequences. However, large sets of data have been generated and are
being generated with the earlier microarray generations. Thus, re-
analysis of these data could provide more detailed information of
transcript expression using transcript-specific probe sets.
This approach was employed by aligning the probe sequences of
the Affymetrix Array HG-U133A to the Ensembl transcript
sequences and selecting transcript-specific probes to build
transcript-specific probe sets. We found that the probe sequences
on the HG-U133A were sufficient to distinguish multiple
transcript intensities for 215 genes (or 141 genes with a minimum
probe set size of 3). In our proof-of-concept application, four
selected transcripts with different expression levels in the kidney
were identified and renal expression confirmed by real-time RT-
PCR. As the intensity of a probe depends not only on the
concentration of its complementary transcript but also on its
sequence, such an approach may be problematic. Therefore,
disease-associated and transcript-specific differential expression
was also studied. Again, both predicted expression patterns were
supported by real-time RT-PCR experiments.
Figure 1. Intensity histograms of several probe categories.
Gene-specific and transcript-specific probes show more high intensity
signals as compared to non-perfect or no-match probes. a) Probe
intensities of one microarray (LD2) were RMA-background-adjusted and
logarithmized (base 2). Probes were assigned to categories shown in
the legend as defined in the results section. The normalized intensities
of each category are put into 100 evenly-spaced intervals and plotted as
histogram. The probe intensity 95%-quantile of Affymetrix-defined
negative control probe sets is plotted in yellow. b) As the number of
probes varies between the different categories it is hard to compare the
shapes of the distributions in a). Therefore, the histograms were
normalized with their number of probes in this plot. Averaging over
multiple arrays instead of analyzing one array gives similar results.
doi:10.1371/journal.pone.0004702.g001
Transcript Analysis
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Different groups reported recently their approaches to map
probe sequences of Affymetrix microarrays to transcript sequenc-
es. Some of these mention transcript-specific analysis as a possible
application, however, a confirmation of a predicted transcript
expression by independent means such as real-time RT-PCR has
not yet been reported. Dai et al. [5] aligned probe sequences of
several microarrays to transcript sequences from different
databases and derived ‘‘transcript-specific’’ probe sets. However,
as the authors noted, this implies redundancies in related probe set
definitions, such as shared probes among different transcripts from
the same gene. The intensities of the transcript-specific probes may
be lost for the intensity of the probe set. Liu et al. provided
AffyProbeMiner [6], which aligns probe sequences to RefSeq (or
RefSeq plus GenBank) complete coding sequences. It allows users
to choose parameters how probe sets are built. One allowed
combination of parameters, in their paper called ‘‘transcript-
unique probe sets’’, is similar to the probe set definition used in our
present study. However, we excluded probes having an alignment
with one mismatch and used Ensembl instead of RefSeq (plus
GenBank). AffyProbeMiner defines 10,226 (6,878 for RefSeq plus
GenBank) probe sets, whereas our approach yields 7,941 probe
sets (of these 3,412 (1,776) probe sets are identical between the two
approaches). Lu et al. [7] also reported a similar approach but
using AceView as the reference database. They could show that
cross-platform comparability is improved when the transcriptome
is analyzed by a transcript-specific approach and a minimum
probe set size of four is used. Our group recently reported a study
showing improved elucidation of biological processes by single-
probe analysis. In this study a commercially available software,
ChipInspector, was used, which also employs a re-annotation of
probe sequences but uses in house annotation and does not
employ probe set definition [12].
Beside these transcript-specific re-annotation approaches an
exon-based analysis would be a promising strategy. Such an exon-,
instead of transcript-based analysis would offer the advantage of
less transcript annotation changes. But applying this approach to
routine arrays such as the HG-U133A means fewer probes per
probe set and would subsequently reduce the statistical power for
determining expression changes. Only the latest generation of
exon-specific microarrays yield sufficient data for such an
approach.
Our study used a re-annotation approach similar to some of the
above reports. Other researchers published web-based tools for the
mapping of probe sets to known splice isoforms [13,14] or used
different databases like the International Protein Index [15] or
GeneAnnot [16].
But none of these studies supported the bioinformatics data by
additional experimental validation. In the present study we
validated the expression change of four specific transcripts by
real-time RT-PCR. These transcripts were selected as a sufficient
number of probes for each transcript showed minor overlap in
probe intensities. For PLG, the gene for plasminogen, we observed
higher overall expression of the transcript PLMN_HUMAN
compared to Q5TEH5_HUMAN in the human kidney. Further-
more, the mRNA for the transcript PLMN_HUMAN was reduced
in organs from deceased kidney donors compared to living donors.
As plasminogen is mainly synthesized in the kidney the results are
in agreement with PLMN_HUMAN being the main transcript of
the PLG gene and it seems that its expression is rapidly reduced in
a deceased organism. Although it is well-established that the
regulation of plasminogen activation plays a crucial role in kidney
disease [17], it is difficult to speculate on the biological relevance of
the transcript-specific findings for PLG as only little is known
about the functions of the two PLG transcripts. The finding of the
Table 2. Genes having transcripts with transcript-specific probes.
number of known
transcripts
genes with 1 matched
transcript
genes with 2 matched
transcripts
genes with 3 matched
transcripts
genes with 4 matched
transcripts
genes with 5 matched
transcripts
1 5447
2 1162 99
3 480 49 2
4 192 25 2 1
5 95 11 3
6 54 2 1
7 27 5
8 16 3
9 9 4
10 4 1 1 1
11 4 2
12 1
13 1
14 1
15 1
16 1
17 1
18 1
sum 7496 204 8 2 1
The fraction of transcripts that were matched by transcript-specific probes, listed by total number of known transcripts in Ensembl, are shown. For example, 99 genes
had 2 known transcripts and both had at least one transcript-specific probe, while 1,162 had a transcript-specific probe set (of size.= 1) for only one transcript.
doi:10.1371/journal.pone.0004702.t002
Transcript Analysis
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transcript-specific expression pattern of PPM1A, a protein serine/
threonine phosphatase capable of dephosphorylating Smad1 to
terminate TGFbeta signaling [18], may well have biological
relevance as Smad- and TGF beta-related biological processes are
crucial for the progression of kidney diseases [19]. But again the
knowledge about the functional differences of the specific
transcripts is still limited. With respect to the increased renal
synthesis of one transcript of ABCA1, coding for a cholesterol
efflux pump, observed in DN it is obvious that this may represent
the response of the kidney to the metabolic changes in long-
standing diabetes mellitus including hypercholesteremia, protein-
uria and lipiduria [20].
The examples on PLG, PPM1A, and ABCA1 clearly show that
for most transcripts the information about their specific biological
functions is still limited. However, employing tools like the one
defined above will help to increase our knowledge on transcript-
specific regulatory events in human disease and animal models.
Re-annotation of probe sequences of conventional microarrays
can be employed to define transcript-specific probe sets. (Re)-
analyses of established microarray data by transcript-specific probe
set definitions are feasible and can give reliable results. This was
exemplarily shown on a, although limited, number of genes and
transcripts.
Methods
Procurement of RNA Samples
Human renal biopsy specimens and HG-U133A (Affymetrix)
microarray expression data thereof were procured in an
international multicenter study, the European Renal cDNA Bank
- Kroener-Fresenius biopsy bank (ERCB-KFB). The protocol for
tissue preparation and mRNA isolation has been reported
elsewhere [21]. Diagnostic renal biopsies were obtained from
patients after informed consent and with approval of the local
ethics committees. The microarray expression data used in this
study came from individual diabetic patients with established
diabetic nephropathy and renal insufficiency (DN; n= 10) as well
as deceased allograft donors (DD; n= 4). Pre-transplantation
kidney biopsies from living donors (LD; n= 3) were used as control
renal tissue. Microdissected samples taken from the tubulo-
interstitial compartment were processed as described [9].
Figure 2. Comparison of alternative transcript abundance in microarray and real-time RT-PCR. On the left microarray signal intensities
are shown for the genes PPM1A and PLG. Confirmatory real-time RT-PCR data are shown on the right. Lowly and highly abundant transcripts of the
genes PPM1A and PLG were measured using microarrays in LD tissue. Transcript-specific probe intensities were background-adjusted and quantile-
normalized using RMA. These are shown as single probe values (triangles) and, furthermore, as summarized transcript-specific probe set values (dots).
In addition, the transcripts were quantified in the unaffected part of TN tissue using real-time RT-PCR. Real-time RT-PCR data are normalized to the
transcript with lower abundance.
doi:10.1371/journal.pone.0004702.g002
Table 3. Significance analysis of intensity differences
between alternative transcripts of two genes.
gene transcript SAM fold change
SAM
q-value
probe
set size
PLG PLMN_HUMAN 0.264 (LD vs. DD) 0.057 9
Q5TEH5_HUMAN 0.888 (LD vs. DD) 0.182 6
ABCA1 ABCA1_HUMAN 1.516 (LD vs. DN) 0.053 16
Q5VYS0_HUMAN 0.891 (LD vs. DN) 0.326 10
The microarray intensities for transcript-specific probe sets of gene PLG (ABCA1)
were compared between LD and DD (DN). Fold change indicates the induction
or repression of the respective transcript compared to the healthy LD controls.
doi:10.1371/journal.pone.0004702.t003
Transcript Analysis
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Probe and Transcript Sequences and BLAST
HG-U133A Affymetrix ‘‘perfect match probe’’ sequences and
coordinates (247,965 sequences) were downloaded from the
Affymetrix support web page [22]. Transcript sequences (44,676
sequences) were extracted from Ensembl ftp release 42 [23].
Probes were aligned to transcript sequences using BLAST version
2.2.15. Probe, transcript, alignment, probe set and array data were
stored in a MySQL 5.0 database.
Figure 3. Microarray and real-time RT-PCR transcript measurements of PLG and ABCA1 in two patient cohorts. For the gene PLG,
transcript PLMN_HUMAN was repressed in DD compared to LD controls, while Q5TEH_HUMAN showed no differential expression. Real-time RT-PCR
measurements on the same tissues were in agreement with these findings. For gene ABCA1, transcript ABCA1_HUMAN was induced in DN compared
to LD, and Q5VYS0_HUMAN was not regulated. Real-time RT-PCR measurement confirmed the induction of ABCA1_HUMAN. Q5VYS0_HUMAN was
expressed at a too low level to be measured (value 0). Real-time data are normalized to the cohort with lower abundance.
doi:10.1371/journal.pone.0004702.g003
Transcript Analysis
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Gene- and Transcript-specific Probes and Probe sets
The transcript sequenceswereput intoa localBLAST[24]database
using the formatdb program. blastall options were ‘‘-e 1 -m 8 -p blastn -
F F’’. Low-complexity filtering of query sequences was turned off in
order to find all possible hits. Only alignments with an E-value,1.0
were returned. Blastn parameters for match/mismatch score, gap
open and gap extension cost were left at their default settings.
Finding exact alignments between probe and transcript sequences
was used to attribute signal intensities of probes to transcript (or gene)
expression. Therefore, probes were categorized as ‘‘transcript-
specific’’ if their exact hits (100% identity over 25 base pairs) were
to one transcript only and ‘‘gene-specific’’ if their exact hits were to
(possiblymore than one) transcripts of a single gene only. This means
that transcript-specific probes are a subset of gene-specific probes.
Probes with any single mismatch were excluded. Overall, of the
247,965 probes, 180,403 were gene- and 95,008 were transcript-
specific. Only the Affymetrix ‘‘perfect match (PM) probes’’ were
analyzed as we found that including the ‘‘mismatch (MM) probes’’
would yield only 16 additional transcript-specific probes.
According to above definition of gene- and transcript-specific
probes, these were grouped as gene- or transcript-specific probe sets.
For example, two gene-specific probes both matching the same
transcripts of the same genewere grouped into the same gene-specific
probe set. To select transcripts for independent quantification only
the transcript-specific probe set intensities were used for this study.
To facilitate microarray analysis using the Bioconductor affy library
[25], the transcript-specific probe set definitions were stored in a
CDF file using the Bio::Affymetrix::CDF perl module [26].
Selection of Transcripts for Confirmatory Experiments
For the organ specific analysis, expression data from LD were
background corrected with the ‘‘rma’’ method and normalized
with the ‘‘quantiles’’ method using the R affy library [25]. Genes
were then ordered by an ad-hoc method (fitting the probe intensity
histogram with a mixture of two gamma distributions, representing
low and high intensities of probes, and computing the relative
probability that transcripts are from the first or second
distribution). Two genes were manually selected, each with two
known isoforms and different intensities.
To find genes that showed two transcripts with different expression
between two patient cohorts, microarray expression data were
background-corrected and quantile normalized as described above.
This was done separately for LD vs. DD and LD vs. DN. The
normalized probe intensities were summarized using the generated
transcript-specific CDF environment. These data were then
analyzed for fold changes and q-values between two different patient
cohorts using the ‘‘sam’’ function in the ‘‘siggenes’’ R library [27].
From all genes, we extracted the ones with differential expression of
specific transcripts. Only genes with at least two transcript-specific
probe sets, with at least one transcript having a q-value,0.1 andwith
a quotient of the maximal/minimal transcript fold change greater
than 1.5 were considered for independent quantification. Addition-
ally, we avoided selecting genes with less than three probes per
transcript-specific probe set.
Real-Time RT-PCR Confirmatory Experiments
For validation of the microarray data, real-time RT-PCR
transcript quantification analyses were performed on cDNA used
in the microarray experiments as well as on samples from the
unaffected part of tumor nephrectomies (TN; n= 6).
Real-time RT-PCR was performed on an ABI PRISM 7700
Sequence Detection System (‘‘TaqMan’’, Applied Biosystems,
Darmstadt, Germany) using heat-activated TaqDNA polymerase
(Amplitaq Gold; Applied Biosystems). After an initial hold of two
minutes at 50uC and tenminutes at 95uC, the samples were cycled at
95uC for 15 seconds and 60uC for 60 seconds. For normalization,
commercially available pre-developed TaqMan reagents were used
for the housekeeper gene 18S rRNA (Applied Biosystems).
Oligonucleotide primers (300 nmol/L) and probe (100 nmol/L)
used are listed in Table 4. All primers, including the primers for
Table 4. Primers used for real-time RT-PCR.
gene transcript
primer
direction position
primer
length primer sequence
product
size
PPM1A P35813-2 forward 1274 24 CCTGTTTGTATAAGGGAAGTCGAG 195
reverse 1468 27 AAGTTTGATTGTGTTGAAGATTTTTCT
PP2CA_HUMAN forward 1136 24 CCTGTTTGTATAAGGGAAGTCGAG 248
reverse 1384 20 CATTCCTCTTGCTTGCCAAT
PLG Q5TEH5_HUMAN forward 1015 24 GAGTTTTAGGCCAAATCTGAGAAA 109
probe 1043 33 CAAAGATGACTATGTTTGGGACTGAAGTAAGCA
reverse 1123 20 TTGCTCCACAATTTGAGTCG
PLMN_HUMAN forward 905 20 AAAACTATCGCGGGAATGTG 110
probe 956 25 ACTGGAGTGCACAGACCCCTCACAC
reverse 1014 20 TTTGCAGGGGAAGTTTTCTG
ABCA1 ABCA1_HUMAN forward 1670 21 CTTCATGGAGAACAGCCAAGA 76
probe 1691 25 AATGGACCTTGTCCGGATGCTGTTG
reverse 1745 21 TTCCCAAAAGTGGTCATTGTC
Q5VYS0_HUMAN forward 990 21 AGCGAGTACTTCGTTCCAACA 77
probe 1018 25 CCTGAAGCCAATCCTGATGGATGTG
reverse 1066 19 CCCATGTGCAATGTCATCA
These primers were used for quantification of highly and lowly abundant renal mRNA transcripts and difference between renal mRNA transcripts. PPM1A transcripts’
intensities were measured using SYBR Green, while those of PLG and ABCA1 were measured using an internal fluorescent probe.
doi:10.1371/journal.pone.0004702.t004
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Q5VYS0, gave positive signals on whole kidney mRNA. Water and
no template controls were negative (Ct.40).
Statistics
Significance testing (one-sided t-test) results were considered to
be significant for p-values smaller than 5%. They were computed
using Gnumeric version 1.6.3 [28]. The SAM q-value can be
interpreted analogous to a p-value that is corrected for multiple
testing.
Supporting Information
Table S1 List of Ensembl transcript identifiers of the 7,941
transcripts covered by transcript-specific probe sets.
Found at: doi:10.1371/journal.pone.0004702.s001 (0.13 MB
TXT)
Table S2 List of genes with multiple transcripts covered by the
defined transcript-specific probe sets. For 215 genes, two or more
transcripts were covered by transcript-specific probe sets with a
minimal probe set size of 1. This table lists those genes along with
the covered 445 transcripts.
Found at: doi:10.1371/journal.pone.0004702.s002 (0.01 MB
TXT)
Dataset S1 CDF file describing the transcript-specific probe
sets. The transcript-specific probe set definitions were stored in a
CDF file using the Bio::Affymetrix::CDF perl module. For use in
some analysis tools it may be necessary to rename this CDF file to
the default Affymetrix file name (‘‘HG-U133A.CDF’’).
Found at: doi:10.1371/journal.pone.0004702.s003 (2.87 MB ZIP)
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